As an emerging next-generation probiotic, PG can reduce the levels of pro-inflammatory cytokines IL-1β and TNF-α in mice with colitis, alleviate inflammatory damage, and maintain the integrity of the intestinal epithelium (43). Here, TNF is linked to colitis.